• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种日常功能状态疼痛评估工具的初步效度

Preliminary validity of a daily functional status pain assessment tool.

作者信息

Smith Wally R, Qayyum Rehan, Ulbing Alexandra, Guy Margaret S, Sop Daniel M, Zhang Yue May

机构信息

Division of General Internal Medicine, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23219-0306, United States.

Department of Internal Medicine, Macon & Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, VA 23501-1980, United States.

出版信息

J Sick Cell Dis. 2025 Feb 19;2(1):yoaf006. doi: 10.1093/jscdis/yoaf006. eCollection 2025.

DOI:10.1093/jscdis/yoaf006
PMID:40123944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11925492/
Abstract

OBJECTIVES

Readiness for discharge for a SCD vaso-occlusive crisis is dictated by factors far beyond pain control, including physical function/activity. We therefore designed and tested a functional status-based pain assessment questionnaire in SCD patients hospitalized with vaso-occlusive crises.

METHODS

Sickle cell disease patients on a preselected nursing unit rated 10 draft Functional status-Based Pain Assessment items of activities of daily living on a five-point Likert scale (0-5) from "very easy" to "very difficult" daily on each day of their admission until discharge, at approximately the same time. Concurrently, they reported Numeric Rating Scale (0-10) pain intensity. For validation, we used exploratory factor analysis, confirmatory factor analysis, and item response theory analysis.

RESULTS AND DISCUSSION

We analyzed 503 observations from 175 admissions of 88 patients. Half were female, the mean age was 32.1 ± 11.8 years, and the mean length of stay was 7.1 ± 6.9 days. The mean Numeric Rating Scale (6.8 ± 1.9) was inversely correlated with the mean Functional Status-based Pain Assessment (0-50) score (27 ± 8.0, = -0.4342, < .0001). Functional Status-based Pain Assessment item means ranged from 2.1 to 3.3. Cronbach's alpha was 0.91. Exploratory factor analysis showed that all Functional Status-based Pain Assessment items loaded on a single factor. Confirmatory factor analysis found adequate convergent and discriminant validity and showed strong fit of the model to the data. Item response theory analysis showed item discrimination ranging from 0.56 to 4.1, while difficulty ranged from -2.8 to 7.5.

CONCLUSION

The Functional Status-based Pain Assessment shows strong correlation with daily Numeric Rating Scale, is multidimensional, and demonstrates strong construct validity. It may improve assessment of SCD vaso-occlusive crisis pain and may enhance vaso-occlusive crisis discharge discussions.

摘要

目的

镰状细胞贫血(SCD)血管闭塞性危象患者出院的准备情况取决于疼痛控制之外的诸多因素,包括身体功能/活动能力。因此,我们设计并测试了一种针对因血管闭塞性危象住院的SCD患者的基于功能状态的疼痛评估问卷。

方法

在一个预先选定的护理单元中,镰状细胞病患者在入院直至出院的每一天,大约在同一时间,对10项基于功能状态的日常生活活动疼痛评估草案项目按照从“非常容易”到“非常困难”的五点李克特量表(0 - 5)进行评分。同时,他们报告数字评定量表(0 - 10)的疼痛强度。为进行验证,我们采用了探索性因素分析、验证性因素分析和项目反应理论分析。

结果与讨论

我们分析了88例患者175次入院的503份观察资料。其中一半为女性,平均年龄为32.1±11.8岁,平均住院时间为7.1±6.9天。数字评定量表的平均分(6.8±1.9)与基于功能状态的疼痛评估(0 - 50)平均分(27±8.0)呈负相关(r = -0.4342,P <.0001)。基于功能状态的疼痛评估项目平均分在2.1至3.3之间。克朗巴哈系数为0.91。探索性因素分析表明,所有基于功能状态的疼痛评估项目均加载于一个单一因素上。验证性因素分析发现有足够的收敛效度和区分效度,并表明模型与数据拟合良好。项目反应理论分析表明项目区分度在0.56至4.1之间,而难度在 -2.8至7.5之间。

结论

基于功能状态的疼痛评估与每日数字评定量表显示出强相关性,具有多维性,并表现出强结构效度。它可能会改善对SCD血管闭塞性危象疼痛的评估,并可能加强关于血管闭塞性危象出院的讨论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ea/11925492/3a0d110f83fb/yoaf006f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ea/11925492/a81148513ef7/yoaf006f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ea/11925492/b4fdd9785df3/yoaf006f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ea/11925492/6916c03cdbc7/yoaf006f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ea/11925492/7bba1f31178e/yoaf006f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ea/11925492/5a38eb07e8ab/yoaf006f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ea/11925492/150ae448434e/yoaf006f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ea/11925492/3a0d110f83fb/yoaf006f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ea/11925492/a81148513ef7/yoaf006f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ea/11925492/b4fdd9785df3/yoaf006f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ea/11925492/6916c03cdbc7/yoaf006f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ea/11925492/7bba1f31178e/yoaf006f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ea/11925492/5a38eb07e8ab/yoaf006f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ea/11925492/150ae448434e/yoaf006f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39ea/11925492/3a0d110f83fb/yoaf006f7.jpg

相似文献

1
Preliminary validity of a daily functional status pain assessment tool.一种日常功能状态疼痛评估工具的初步效度
J Sick Cell Dis. 2025 Feb 19;2(1):yoaf006. doi: 10.1093/jscdis/yoaf006. eCollection 2025.
2
Development and validation of the sickle cell stress scale-adult.镰状细胞应激量表-成人版的编制与验证。
Eur J Haematol. 2022 Sep;109(3):215-225. doi: 10.1111/ejh.13789. Epub 2022 Jun 3.
3
Assessment of health-related quality of life among adults hospitalized with sickle cell disease vaso-occlusive crisis.镰状细胞病血管闭塞性危象住院成人患者的健康相关生活质量评估。
Blood Adv. 2020 Jan 14;4(1):19-27. doi: 10.1182/bloodadvances.2019000128.
4
Validation of patient-reported vaso-occlusive crisis day as an endpoint in sickle cell disease studies.验证患者报告的血管阻塞性危象日作为镰状细胞病研究的终点。
Eur J Haematol. 2022 Sep;109(3):226-237. doi: 10.1111/ejh.13790. Epub 2022 Jun 20.
5
Impact of Hydroxyurea Therapy in Reducing Pain Crises, Hospital Admissions, and Length of Stay Among Sickle Cell Patients in the Eastern Region of Saudi Arabia.羟基脲疗法对沙特阿拉伯东部地区镰状细胞病患者减少疼痛危象、住院次数及住院时长的影响
Cureus. 2022 Nov 15;14(11):e31527. doi: 10.7759/cureus.31527. eCollection 2022 Nov.
6
Health care provider attitudes toward patients with acute vaso-occlusive crisis due to sickle cell disease: development of a scale.医疗保健提供者对镰状细胞病所致急性血管阻塞性危象患者的态度:量表的制定。
Patient Educ Couns. 2009 Aug;76(2):272-8. doi: 10.1016/j.pec.2009.01.007. Epub 2009 Feb 23.
7
The Association between Adenotonsillectomy and Frequency of Vaso-Occlusive Crises in Patients with Sickle Cell Disease.腺样体扁桃体切除术与镰状细胞病患者血管闭塞性危象发生频率之间的关联
Indian J Otolaryngol Head Neck Surg. 2022 Dec;74(Suppl 3):5499-5505. doi: 10.1007/s12070-021-02696-5. Epub 2021 Aug 22.
8
Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.磁共振成像评估镰状细胞血管阻塞危象期间肾脏的氧合和灌注。
Am J Kidney Dis. 2017 Jan;69(1):51-59. doi: 10.1053/j.ajkd.2016.07.027. Epub 2016 Sep 20.
9
Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis.小儿镰状细胞血管阻塞性疼痛危象期间的急性肾损伤
Pediatr Nephrol. 2017 Aug;32(8):1451-1456. doi: 10.1007/s00467-017-3623-6. Epub 2017 Feb 25.
10
Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.成人疼痛性镰状细胞血管闭塞性危象的药物干预措施。
Cochrane Database Syst Rev. 2019 Nov 14;2019(11):CD012187. doi: 10.1002/14651858.CD012187.pub2.

本文引用的文献

1
Sample size in quantitative instrument validation studies: A systematic review of articles published in Scopus, 2021.定量仪器验证研究中的样本量:对2021年发表在Scopus上的文章的系统评价
Heliyon. 2022 Dec 12;8(12):e12223. doi: 10.1016/j.heliyon.2022.e12223. eCollection 2022 Dec.
2
A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis.利维帕奈用于镰状细胞血管阻塞性危机的疗效和安全性的随机临床试验。
Blood. 2023 Jan 12;141(2):168-179. doi: 10.1182/blood.2022015797.
3
Sickle cell disease.
镰状细胞病。
Nat Rev Dis Primers. 2018 Mar 15;4:18010. doi: 10.1038/nrdp.2018.10.
4
Standard measures for sickle cell disease research: the PhenX Toolkit sickle cell disease collections.镰状细胞病研究的标准测量方法:PhenX工具包镰状细胞病数据集。
Blood Adv. 2017 Dec 15;1(27):2703-2711. doi: 10.1182/bloodadvances.2017010702. eCollection 2017 Dec 26.
5
Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use.GMI-1070用于镰状细胞病的随机2期研究:血管闭塞性事件缓解时间缩短且阿片类药物使用减少。
Blood. 2015 Apr 23;125(17):2656-64. doi: 10.1182/blood-2014-06-583351. Epub 2015 Mar 2.
6
Development and validation of the Youth Acute Pain Functional Ability Questionnaire (YAPFAQ).青年急性疼痛功能能力问卷(YAPFAQ)的编制和验证。
J Pain. 2014 Dec;15(12):1319-27. doi: 10.1016/j.jpain.2014.09.008. Epub 2014 Sep 30.
7
Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance.系统性红斑狼疮临床试验的患者报告结局指标:内容效度、表面效度和心理测量性能综述
Health Qual Life Outcomes. 2014 Jul 22;12:116. doi: 10.1186/s12955-014-0116-1.
8
Validation of the sickle cell disease pain burden interview-youth.镰状细胞病疼痛负担访谈-青少年验证。
J Pain. 2013 Sep;14(9):975-82. doi: 10.1016/j.jpain.2013.03.007. Epub 2013 May 20.
9
Measures of juvenile fibromyalgia: Functional Disability Inventory (FDI), Modified Fibromyalgia Impact Questionnaire-Child Version (MFIQ-C), and Pediatric Quality of Life Inventory (PedsQL) 3.0 Rheumatology Module Pain and Hurt Scale.青少年纤维肌痛的测量指标:功能残疾量表(FDI)、改良纤维肌痛影响问卷儿童版(MFIQ-C)以及儿童生活质量量表(PedsQL)3.0风湿病模块疼痛与伤害量表。
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11(0 11):S431-7. doi: 10.1002/acr.20639.
10
The PhenX Toolkit: get the most from your measures. PhenX 工具包:充分利用您的测量结果。
Am J Epidemiol. 2011 Aug 1;174(3):253-60. doi: 10.1093/aje/kwr193. Epub 2011 Jul 11.